Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - everolimus, quantity: 2.5 mg - tablet - excipient ingredients: magnesium stearate; lactose; lactose monohydrate; hypromellose; butylated hydroxytoluene; crospovidone - afinitor is indicated for the treatment of:,? postmenopausal women with hormone receptor-positive, her2 negative advanced breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. ? progressive, unresectable or metastatic, well or moderately differentiated neuroendocrine tumours (nets) of pancreatic origin. ? progressive, unresectable or metastatic, well-differentiated, non-functional neuroendocrine tumours (net) of gastrointestinal or lung origin in adults. ? advanced renal cell carcinoma after failure of treatment with sorafenib or sunitinib. ? subependymal giant cell astrocytoma (sega) associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection. ? patients with tuberous sclerosis complex (tsc) who have renal angiomyolipoma not requiring immediate surgery. afinitor is indicated for the: ? treatment of postmenopausal women with hormone receptor-positive, her2 negative advanced breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. ? treatment of progressive, unresectable or metastatic, well or moderately differentiated neuroendocrine tumours (nets) of pancreatic origin. ? treatment of progressive, unresectable or metastatic, well-differentiated, non-functional neuroendocrine tumours (net) of gastrointestinal or lung origin in adults. ? treatment of advanced renal cell carcinoma after failure of treatment with sorafenib or sunitinib. ? treatment of subependymal giant cell astrocytoma (sega) associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection. ? treatment of patients with tuberous sclerosis complex (tsc) who have renal angiomyolipoma not requiring immediate surgery. ? adjunctive treatment of patients aged 2 years and older with tsc and associated refractory seizures.

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

lambert chemicals co. ltd - turpentine oil pine oil methyl salicylate camphor -

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

johnson & johnson (new zealand) limited - camphor 1%{relative};  ; capsicum 0.76%{relative}; cineole 1%{relative}; menthol 4%{relative};  ; methyl salicylate 10%{relative};  ; pine oil 1.2%{relative}; turpentine oil 2%{relative} - topical cream - active: camphor 1%{relative}   capsicum 0.76%{relative} cineole 1%{relative} menthol 4%{relative}   methyl salicylate 10%{relative}   pine oil 1.2%{relative} turpentine oil 2%{relative} excipient: carbomer glycerol glyceryl monostearate lanolin liquid paraffin macrogol stearate 2500 methyl hydroxybenzoate purified water trolamine

Nigeeria - inglise - NAFDAC (National Agency for Food and Drugs Administration and Control)

capsicum oleoresin8.89mg camphor 4mg methylsalicylate 31.319mg pine oil turpentine oil 425.769mg

Nigeeria - inglise - NAFDAC (National Agency for Food and Drugs Administration and Control)

methyl salicylate 31.319mg,camphor 4mg, oleoresin capsicum 5.879mg,oil turpentine 425.769mg/ml

Lõuna-Aafrika Vabariik - inglise - South African Health Products Regulatory Authority (SAHPRA)

cipla medpro (pty) ltd - cream - see ingredients - each 100 g cream contains capsicum oleoresin 0,25 g methyl nicotinate 0,75 g methyl salicylate 5 g

Lõuna-Aafrika Vabariik - inglise - South African Health Products Regulatory Authority (SAHPRA)

cipla medpro (pty) ltd - liquid - see ingredients - eacn 1 ml contains camphor 4 mg capsicum oleoresin 5,88 mg methyl salicylate 31,32 mg turpentine oil 425,77 mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - estradiol - transdermal patch - 50microgram/24hour

Lõuna-Aafrika Vabariik - inglise - South African Health Products Regulatory Authority (SAHPRA)

litha pharma (pty) ltd - tablet - see ingredients - each tablet contains melatonin 2,0 mg

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - everolimus -